Towards Healthcare
AI and ML in Drug Development Market to Surpass 26% CAGR in Asia Pacific Throu...

AI and ML in Drug Development Market Accelerates in 2025 with Oncology Leading at 36%

Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI and ML, and increasing demand for personalized medicine. 

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Strong growth expected in AI and ML drug development market from 2025–2034, driven by tech advances and funding.

North America is currently leading the AI and ML in drug development market due to advancements in technologies, including AI-powered tools and platforms, rising demand for personalized medicines.

The AI and ML in drug development market includes seven segments, such as by phase of drug development, by technology type, by function/application, by deployment type, by therapeutic area, by end-user, and by region etc.

Some key players include Insilico Medicine, BenevolentAI, Exscientia, Recursion Pharmaceuticals, and Atomwise.

Key trends include rising demand for drug discovery and personalized medicine, growth in technological advancements, and innovation in clinical trials, novel molecules.

The future of AI/ML in drug development includes increased automation, more personalized therapies, faster drug discovery and development, and improved drug safety.

The benefits of ML frameworks for developers are to provide pre-built tools, libraries, and automation to support training, testing, and deploying models rapidly.
Any Questions